Funded Startups in Boulder
Among the 50 most recent Boulder-area rounds shown, the largest disclosed amount is Enliven Therapeutics’ $460M on 2026-06-11, which dwarfs the next-larges…
Among the 50 most recent Boulder-area rounds shown, the largest disclosed amount is Enliven Therapeutics’ $460M on 2026-06-11, which dwarfs the next-largest disclosed rounds (Viridian Therapeutics at $225M on 2026-05-06 and Vero Networks at $425M on 2026-04-06). The smallest disclosed amount is $20K, held by Piña Designs on 2024-10-22, creating a wide disclosed-range spread from $20K to $460M.
The list also clusters tightly in time: there are 10 entries dated in April 2026 alone (including $460M on 6/11, $225M on 5/6, and several Seed rounds), while the oldest shown rounds date back to 2024-10-08 (Fortius Metals, $2M). Sector-wise, Biotechnology is the most frequent category, appearing in at least 5 entries (e.g., Enliven Therapeutics 2026-06-11 $460M, Viridian Therapeutics 2026-05-06 $225M, Think Bioscience 2026-01-20 $55M, and Enveda Biosciences 2025-02-27 $20M). Stage labels are often not specified: 14 of 50 rows are “Series Unknown” and 1 is explicitly “undisclosed” (TIFIN on 2026-06-29).
Most recent rounds
50 of 164114 more funded startups
This page shows the 50 most recent rounds (back to Oct 2024). The full 164-company history for this listing is available on a paid plan.
Unlock all 164 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
How extreme is the funding-size spread for the most recent Boulder rounds, and which rounds define it?
Enliven Therapeutics’ $460M (2026-06-11) is the largest disclosed round in the 50-row set, while the smallest disclosed amount is Piña Designs’ $20K (2024-10-22). The top tier is separated from most other disclosed rounds, including $225M for Viridian Therapeutics (2026-05-06) and $162M for LongPath Technologies (2024-10-22).
Is there a concentration in the calendar, or are rounds evenly distributed across the shown window?
Funding events cluster heavily in the latest months: April 2026 alone accounts for 10 entries (for example, Schematic $7M on 2026-04-21 and Gravity $7M on 2026-04-15). The shown range spans 2024-10-08 (Fortius Metals $2M) through the most recent date 2026-06-29 (TIFIN, undisclosed), with the densest activity around spring 2026.
Which sectors show up most often, and does the list skew toward life sciences?
Biotechnology is the densest category, with multiple appearances such as Enliven Therapeutics (2026-06-11, $460M), Viridian Therapeutics (2026-05-06, $225M), Think Bioscience (2026-01-20, $55M), and Enveda Biosciences (2025-02-27, $20M). Healthcare also appears repeatedly (e.g., Sonoma Pharmaceuticals $4M on 2026-04-24 and Althea $1M on 2025-11-07), reinforcing life-science weighting relative to single-occurrence sectors.
How much of the list lacks disclosed stage or disclosed amount, and what does that imply for comparisons?
Stage is frequently unspecified: 14 of 50 rows are labeled “Series Unknown,” alongside multiple explicit seed/Series A/Series C entries (e.g., Stedi Series C $50M on 2026-03-24 and TestBox Series A $12M on 2026-03-10). Disclosed amounts are also incomplete: TIFIN on 2026-06-29 is “undisclosed,” and several other companies show “undisclosed,” limiting direct size ranking across all 50 rows.
Are there notable outliers in either geography naming or business type within Boulder-area records?
Geographically, nearly all entries are labeled Boulder, Colorado, with a small number using broader wording like “Boulder, United States” (e.g., nVoq on 2025-09-29 $750K) and “Boulder, Colorado, United States” dominating. Business-type outliers appear in scale and modality: large healthcare/biotech rounds like Enliven Therapeutics’ $460M (2026-06-11) sit alongside much smaller disclosed community/lifestyle or e-commerce entries such as Piña Designs ($20K on 2024-10-22) and Jawa ($4M on 2025-11-09).
Which stage signals appear alongside the highest disclosed rounds, suggesting where large raises concentrate?
The largest disclosed sizes are tied to non-uniform stage labels: Enliven Therapeutics is “Series Unknown” at $460M (2026-06-11), Viridian Therapeutics is also “Series Unknown” at $225M (2026-05-06), and Vero Networks is “Series Unknown” at $425M (2026-04-06). Meanwhile, even when stages are named, the large disclosed amounts span categories like Stedi’s Series C $50M (2026-03-24) and RADICL Defense’s Series A $31M (2026-02-03), indicating scale is not confined to a single named stage.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.